Stay updated on Pembrolizumab for Leptomeningeal Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Leptomeningeal Disease Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The revision label in the UI was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:29:08.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Minor site-wide update to Revision: v3.4.2 and removal of the government funding status notice; no changes to trial content, enrollment, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T04:50:27.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, with guidance to check cc.nih.gov and opm.gov for updates. The page revision version was updated from 3.4.0 to 3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T03:48:18.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The changes are minor UI and metadata updates, including the addition of a Show glossary option and revision/version labels, as well as small wording/capitalization adjustments to several fields; these do not alter core trial content or patient-facing information. There are no changes to the study details, eligibility criteria, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:30:35.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The page now shows a revision updated from v3.3.3 to v3.3.4, with the previous revision label removed and the new revision added. This is a metadata update and does not alter study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:40:10.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    Locations section added with Maryland listed as a site, updating where the trial is conducted. The page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:56:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Leptomeningeal Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.